DE3382194D1 - Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen. - Google Patents

Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen.

Info

Publication number
DE3382194D1
DE3382194D1 DE8383402547T DE3382194T DE3382194D1 DE 3382194 D1 DE3382194 D1 DE 3382194D1 DE 8383402547 T DE8383402547 T DE 8383402547T DE 3382194 T DE3382194 T DE 3382194T DE 3382194 D1 DE3382194 D1 DE 3382194D1
Authority
DE
Germany
Prior art keywords
same
compositions containing
immunogenic compositions
malaria parasites
inducing antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8383402547T
Other languages
English (en)
Inventor
Des Erfinders Auf Nennung Verzicht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8221817A external-priority patent/FR2538252B3/fr
Priority claimed from FR8221818A external-priority patent/FR2538253B1/fr
Priority claimed from FR8312496A external-priority patent/FR2549725B2/fr
Priority claimed from FR8320510A external-priority patent/FR2556971B2/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE3382194D1 publication Critical patent/DE3382194D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/822—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8383402547T 1982-12-27 1983-12-27 Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen. Expired - Fee Related DE3382194D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8221817A FR2538252B3 (fr) 1982-12-27 1982-12-27 Fraction polypeptidique de poids moleculaire moyen 100 000 inductrice d'anticorps protecteurs contre des parasites du paludisme et compositions immunogenes les contenant
FR8221818A FR2538253B1 (fr) 1982-12-27 1982-12-27 Fraction polypeptidique de poids moleculaire moyen 75 000 inductrice d'anticorps protecteurs contre des parasites du paludisme et compositions immunogenes les contenant
FR8312496A FR2549725B2 (fr) 1983-07-28 1983-07-28 Fractions polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogenes les contenant
FR8320510A FR2556971B2 (fr) 1983-12-21 1983-12-21 Fractions polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogenes les contenant

Publications (1)

Publication Number Publication Date
DE3382194D1 true DE3382194D1 (de) 1991-04-11

Family

ID=27446443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383402547T Expired - Fee Related DE3382194D1 (de) 1982-12-27 1983-12-27 Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen.

Country Status (7)

Country Link
US (1) US5032397A (de)
EP (1) EP0112784B1 (de)
KR (1) KR910005702B1 (de)
AU (1) AU578890B2 (de)
DE (1) DE3382194D1 (de)
OA (1) OA07800A (de)
WO (2) WO1984002471A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US5153129A (en) * 1982-12-27 1992-10-06 Institut Pasteur Membrane protein having proteolytic activity obtainable from plasmodium falciparum blood schizonts and merozoites
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
FR2589062B1 (fr) * 1985-10-28 1990-05-04 Inst Nat Sante Rech Med Antigenes obtenus a partir de la phase intraerythrocytaire de plasmodium falciparum, leur purification, leur dosage ainsi que celui de leurs anticorps, et vaccins contre le paludisme les renfermant
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
US4906564A (en) * 1987-03-13 1990-03-06 The United States Of America As Represented By The Secretary Of The Army Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens
FR2615104B1 (fr) * 1987-05-14 1989-08-18 Centre Nat Rech Scient Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme
IT1226712B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Metodo immunoenzimatico elisa monopiastra con inibizione competitiva per la rivelazione di anticorpi antisporozoitari di plasmodium falciparum.
AU645482B2 (en) * 1988-09-16 1994-01-20 Statens Serum Institut A malaria antigen
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
FR2665365B1 (fr) * 1990-08-06 1995-04-28 Pasteur Institut Antigene de plasmodium falciparum susceptible d'induire des anticorps protecteurs - application a la vaccination.
FR2665909B1 (fr) * 1990-08-14 1992-11-13 Pasteur Institut Polypeptides de surface de globules rouges infectes par p. falciparum et compositions immunogenes les contenant.
FR2679776A1 (fr) * 1991-07-31 1993-02-05 Pasteur Institut Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
FR2697022B1 (fr) 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298596A (en) * 1979-03-29 1981-11-03 Burroughs Wellcome Co. Trypanosoma cruzi glycoprotein vaccine for inducing immunity to Chagas' disease
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
AU582112B2 (en) * 1982-02-17 1989-03-16 Lawrence E. D'antonio Purification of parasite protective antigen factors
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection

Also Published As

Publication number Publication date
WO1984002472A1 (fr) 1984-07-05
EP0112784A1 (de) 1984-07-04
WO1984002471A1 (en) 1984-07-05
EP0112784B1 (de) 1991-03-06
AU578890B2 (en) 1988-11-10
KR910005702B1 (ko) 1991-08-02
AU2415284A (en) 1984-07-17
KR840006907A (ko) 1984-12-04
OA07800A (fr) 1986-11-20
US5032397A (en) 1991-07-16

Similar Documents

Publication Publication Date Title
BR1100036A (pt) Composto e composição farmacêutica
DE69028346D1 (de) Härtbare Siliconmassen
DE3889320D1 (de) Härtbare Organopolysiloxanzusammensetzung.
DE69014944T2 (de) Härtbare Siloxanzusammensetzungen.
DE68907988T2 (de) Anti-Eiszusammensetzungen.
IT8322845A0 (it) Cosmetico e suo procedimento di preparazione.
DE3382194D1 (de) Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen.
DE3881412T2 (de) Härtbare Zusammensetzungen.
DE3067477D1 (en) Organopolysiloxanes that contain sulfur and curable compositions including the same
IT8323776A0 (it) Carbossi e carbossi sostituiti alcanoil e cicloalcanoil peptidi.
DE3650074D1 (de) Härtbare Silikonzusammensetzung.
DE69110502D1 (de) Härtbare Organopolysiloxan-Massen.
DE3788676D1 (de) Härtbare Organopolysiloxanzusammensetzungen.
FI101480B1 (fi) Kovettuvat fluoresoivat organopolysiloksaanikoostumukset
DE69016298T2 (de) Härtbare Organopolysiloxanzusammensetzungen.
IT1197644B (it) Azepinoindoli,loro preparazione e loro impiego come medicamenti
FI842697A0 (fi) Kosmetiskt preparat.
DE69108765D1 (de) Härtbare Organopolysiloxanzusammensetzung.
IT1169770B (it) Polipeptidi, loro preparazione e loro impiego come medicamenti
FI834204A (fi) Anordning foer haollning av sliden i blixtlaos.
FR2529272B1 (fr) Element d'arret axial
ATE61229T1 (de) Polypeptidfraktionen die gegen malariaparasiten schuetzende antikoerper induzieren und dieselben enthaltende immunogene zusammensetzungen.
FI841902A0 (fi) Insats av icke-metalliskt material.
BR9200203A (pt) Oxido de niobio pirogenicamente preparado
SE7900860L (sv) Skarvhylsa for vajer, hogspenningslinor och liknande

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee